Stephen Jun Fei Chong, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-bcl-2 | 9 | 2024 | 1391 | 1.840 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2023 | 1626 | 1.060 |
Why?
|
| Lymphoma | 2 | 2020 | 1887 | 0.730 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 2085 | 0.730 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2019 | 242 | 0.630 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2024 | 1395 | 0.560 |
Why?
|
| Mitochondria | 3 | 2020 | 3556 | 0.530 |
Why?
|
| Oncogene Proteins | 2 | 2020 | 722 | 0.480 |
Why?
|
| Genes, bcl-2 | 1 | 2014 | 120 | 0.460 |
Why?
|
| Cell Lineage | 1 | 2020 | 2513 | 0.380 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3050 | 0.340 |
Why?
|
| Superoxides | 3 | 2020 | 386 | 0.310 |
Why?
|
| Jurkat Cells | 2 | 2020 | 728 | 0.310 |
Why?
|
| Oxidation-Reduction | 5 | 2021 | 2192 | 0.300 |
Why?
|
| Serine | 2 | 2020 | 827 | 0.270 |
Why?
|
| Protein Phosphatase 2 | 3 | 2020 | 236 | 0.220 |
Why?
|
| Apoptosis | 5 | 2024 | 9429 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 13550 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 5164 | 0.200 |
Why?
|
| Phosphorylation | 4 | 2020 | 8315 | 0.200 |
Why?
|
| Leukemia, Prolymphocytic | 1 | 2021 | 7 | 0.200 |
Why?
|
| bcl-X Protein | 1 | 2023 | 411 | 0.200 |
Why?
|
| Leukemia, Prolymphocytic, T-Cell | 1 | 2021 | 23 | 0.190 |
Why?
|
| DNA Damage | 2 | 2021 | 2407 | 0.190 |
Why?
|
| Melanoma | 1 | 2019 | 5620 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5726 | 0.170 |
Why?
|
| I-kappa B Kinase | 1 | 2020 | 250 | 0.170 |
Why?
|
| Etoposide | 1 | 2020 | 626 | 0.170 |
Why?
|
| Laminin | 1 | 2020 | 403 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 1125 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2019 | 23234 | 0.150 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 329 | 0.150 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 474 | 0.140 |
Why?
|
| Sulfonamides | 3 | 2021 | 1963 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2020 | 543 | 0.130 |
Why?
|
| Fluorouracil | 1 | 2020 | 1605 | 0.130 |
Why?
|
| Oxidants | 1 | 2016 | 169 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10360 | 0.130 |
Why?
|
| Cisplatin | 1 | 2020 | 1643 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 990 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 1172 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 16737 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 2868 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1480 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2020 | 2192 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 8422 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2021 | 5288 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2020 | 2471 | 0.100 |
Why?
|
| Autophagy | 1 | 2020 | 1324 | 0.100 |
Why?
|
| Neoplasms | 2 | 2018 | 21806 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 870 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2020 | 4114 | 0.090 |
Why?
|
| Peroxynitrous Acid | 2 | 2020 | 41 | 0.090 |
Why?
|
| Animals | 8 | 2024 | 166811 | 0.090 |
Why?
|
| Cell Survival | 2 | 2018 | 5771 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3599 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2855 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 929 | 0.080 |
Why?
|
| Antioxidants | 1 | 2016 | 1651 | 0.080 |
Why?
|
| Protein Binding | 1 | 2019 | 9273 | 0.070 |
Why?
|
| Humans | 13 | 2024 | 752411 | 0.060 |
Why?
|
| Mutation | 2 | 2020 | 29706 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2021 | 3582 | 0.060 |
Why?
|
| Mice | 4 | 2024 | 80550 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6304 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13405 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11587 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2021 | 887 | 0.030 |
Why?
|
| Tyrosine | 1 | 2020 | 1440 | 0.030 |
Why?
|
| Nitriles | 1 | 2021 | 955 | 0.030 |
Why?
|
| Adenine | 1 | 2021 | 977 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2021 | 3088 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2910 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2021 | 2930 | 0.030 |
Why?
|
| Piperidines | 1 | 2021 | 1645 | 0.030 |
Why?
|
| Collagen | 1 | 2021 | 2627 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 6112 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1615 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2021 | 1984 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2021 | 2979 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5035 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3755 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5838 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4271 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6166 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58299 | 0.010 |
Why?
|
| Female | 2 | 2021 | 386085 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 166585 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 217039 | 0.000 |
Why?
|
| Male | 1 | 2021 | 354908 | 0.000 |
Why?
|